Subscribe
shutterstock_1857404794_michael_vi
Michael Vi / Shutterstock.com
12 January 2021AmericasMuireann Bolger

Illumina accused of fraud in DNA tech patents dispute

Illumina tried to secure its control over the DNA sequencing technology market by violating antitrust law, according to a suit by BGI Americas and two of its subsidiaries, at the US Court for the District Court of San Francisco.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Europe
Illumina files for patent infringement over prenatal test
8 September 2017   Genetic sequencing company Illumina has filed a patent infringement suit against Premaitha Health, a molecular diagnostics company, in the English High Court.
Americas
Illumina and Cornell University seek to dismiss patent dispute
20 April 2017   Genetic sequencing company Illumina and Cornell University have together sought to dismiss a patent dispute over eight genetic testing patents belonging to Cornell.


Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024

Editor's picks

Americas
UPC bans Meril Life Sciences from selling infringing heart valve
19 November 2024
Americas
Big Pharma counsel embrace AI but data and legal risks loom
24 October 2024
Asia
President Xi sends message to AIPPI’s World Congress
22 October 2024
Unified Patent Court
‘Every CMS filing is painful’: Notes from a Unified Patent Court dispute
26 September 2024
Unified Patent Court
Interview: Klaus Grabinski, UPC Court of Appeal president
24 September 2024
Unified Patent Court
‘Be prepared, and don’t assume at the UPC’: Christopher Stothers
12 September 2024

More on this story

Europe
Illumina files for patent infringement over prenatal test
8 September 2017   Genetic sequencing company Illumina has filed a patent infringement suit against Premaitha Health, a molecular diagnostics company, in the English High Court.
Americas
Illumina and Cornell University seek to dismiss patent dispute
20 April 2017   Genetic sequencing company Illumina and Cornell University have together sought to dismiss a patent dispute over eight genetic testing patents belonging to Cornell.

More on this story

Europe
Illumina files for patent infringement over prenatal test
8 September 2017   Genetic sequencing company Illumina has filed a patent infringement suit against Premaitha Health, a molecular diagnostics company, in the English High Court.
Americas
Illumina and Cornell University seek to dismiss patent dispute
20 April 2017   Genetic sequencing company Illumina and Cornell University have together sought to dismiss a patent dispute over eight genetic testing patents belonging to Cornell.

More features

Bayer gains exclusive licence for heart drug in Japan
EPO delivers key Novo Nordisk, GSK and Inhibrx rulings
McGuireWoods expands team with ex-Novo Nordisk GC
Paul, Weiss swoops for senior duo from Weil, Gotshal
UPC bans Meril Life Sciences from selling infringing heart valve
SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic
Kathi Vidal to rejoin previous firm as partner following USPTO departure
GSK triumphs in EPO appeal, revoking Pfizer patent